Mitchell Levine

Mitchell Levine

Chairman presso IMMUNOPRECISE ANTIBODIES LTD.

Patrimonio netto: 30 400 $ in data 31/03/2024

Finance
Health Technology
Consumer Services

Posizioni attive di Mitchell Levine

SocietàPosizioneInizioFine
IMMUNOPRECISE ANTIBODIES LTD. Chairman 27/11/2023 -
Director/Board Member - 27/11/2023
Chief Executive Officer 01/11/2022 -
Chairman - -

Storia della carriera di Mitchell Levine

Precedenti posizioni note di Mitchell Levine

SocietàPosizioneInizioFine
Chief Investment Officer 01/01/2002 01/01/2017
Compliance Officer 01/01/2002 01/01/2017
Founder 27/07/2011 01/01/2017
Cove Capital Advisors, Inc. Corporate Officer/Principal - -
ONCOCYTE CORPORATION Director of Finance/CFO 15/11/2017 01/06/2022
Corporate Officer/Principal 01/06/2022 -
Lehman Brothers Distressed Structured Credit Capital Partners Corporate Officer/Principal - -
Corporate Officer/Principal - -
Corporate Officer/Principal - -

Formazione di Mitchell Levine

University of California, Davis Undergraduate Degree

Statistiche

Distribuzione geografica

Stati Uniti 9
Canada 2

Posizioni

Corporate Officer/Principal 5
Chairman 2
Chief Investment Officer 1

Settori

Finance 4
Health Technology 4
Consumer Services 2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società collegate

Società quotate in Borsa2
ONCOCYTE CORPORATION

Health Technology

IMMUNOPRECISE ANTIBODIES LTD.

Health Technology

Aziende private6

Finance

Lehman Brothers Distressed Structured Credit Capital Partners

Finance

Finance

Cove Capital Advisors, Inc.

Health Technology

Vedi le connessioni aziendali